165 related articles for article (PubMed ID: 34951001)
1. In Situ Liquid Crystal Gel as a Promising Strategy for Improving Ocular Administration of Dexamethasone: Preparation, Characterization, and Evaluation.
Wu W; Cao W; Chen J; Cai Y; Dong B; Chu X
AAPS PharmSciTech; 2021 Dec; 23(1):36. PubMed ID: 34951001
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
3. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
[TBL] [Abstract][Full Text] [Related]
4. A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.
Wang X; Zhang Y; Huang J; Tian C; Xia M; Liu L; Li Z; Cao J; Gui S; Chu X
AAPS PharmSciTech; 2019 Jan; 20(1):32. PubMed ID: 30603986
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.
Wang X; Zhang Y; Huang J; Xia M; Liu L; Tian C; Hu R; Gui S; Chu X
Int J Pharm; 2019 May; 562():31-41. PubMed ID: 30878587
[TBL] [Abstract][Full Text] [Related]
6. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
7. A Novel Phytantriol-Based In Situ Liquid Crystal Gel for Vaginal Delivery.
Jie H; Liu L; Shuangying G; Xingqi W; Rongfeng H; Yong Z; Chunling T; Mengqiu X; Xiaoqin C
AAPS PharmSciTech; 2019 May; 20(5):185. PubMed ID: 31062112
[TBL] [Abstract][Full Text] [Related]
8. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
9. Dual drug-loaded cubic liquid crystal gels for transdermal delivery: inner structure and percutaneous mechanism evaluations.
Chu X; Wang X; Tian C; Liu L; Xia M; Jiang J; Gui S
Drug Dev Ind Pharm; 2019 Dec; 45(12):1879-1888. PubMed ID: 31672067
[TBL] [Abstract][Full Text] [Related]
10. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
[TBL] [Abstract][Full Text] [Related]
11. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
Khan S; Warade S; Singhavi DJ
J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
[TBL] [Abstract][Full Text] [Related]
12. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
13. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
[TBL] [Abstract][Full Text] [Related]
14. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
[TBL] [Abstract][Full Text] [Related]
15. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z
Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466
[TBL] [Abstract][Full Text] [Related]
17. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
18. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.
Chen Y; Liang X; Ma P; Tao Y; Wu X; Wu X; Chu X; Gui S
AAPS PharmSciTech; 2015 Aug; 16(4):846-54. PubMed ID: 25573438
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical evaluation and pharmacodynamics of itraconazole-loaded liquid crystal precursor for vaginal delivery.
Tian C; Huang J; Xia M; Liu L; Cao W; Chen J; Chu X
Drug Dev Ind Pharm; 2021 Aug; 47(8):1223-1234. PubMed ID: 34779328
[TBL] [Abstract][Full Text] [Related]
20. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
Swaminathan S; Vavia PR; Trotta F; Cavalli R
J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
